BLUME-JENSEN PETER (President and CEO) reported 2 transactions at ACRIVON THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/18/2026ACC: 0000905148-26-002498
DirectorOfficer· President and CEO
Since Mar 2026
-1.74K
Net shares
Net seller
$3.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
1.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.25K
Price / share
$1.92
Trade value
$2.41K
% of position
0.1%
5/14/2026
2.08M→2.08M
Common Stock
Indirect
Shares
−490.00
Price / share
$1.92
Trade value
$940.80
% of position
0.2%
5/14/2026
314.13K→313.64K
Total
Net shares
−1.74K
Net value
-$3.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | F · Tax Withholding | −1.25K | $1.92 | $2.41K | 0.1% | 2.08M | 2.08M |
| Common Stock Indirect | 5/14/2026 | F · Tax Withholding | −490.00 | $1.92 | $940.80 | 0.2% | 314.13K | 313.64K |
| Total | −1.74K | -$3.35K | ||||||
Derivative Transactions0
No derivative transactions reported